Acute oxalate nephropathy associated with orlistat

Background: Obesity is a major world-wide epidemic which has led to a surge of various weight loss-inducing medical or surgical treatments. Orlistat is a gastrointestinal lipase inhibitor used as an adjunct treatment of obesity and type 2 diabetes mellitus to induce clinically significant weight los...

全面介紹

Saved in:
書目詳細資料
Main Authors: Youshay Humayun (Author), Kenneth C. Ball (Author), Jack R. Lewin (Author), Anna A. Lerant (Author), Tibor Fülöp (Author)
格式: 圖書
出版: Society of Diabetic Nephropathy Prevention, 2016-04-01T00:00:00Z.
主題:
在線閱讀:Connect to this object online.
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!